首页> 外文OA文献 >Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients

【2h】

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients

机译：2年和3年的无病生存率是一个重要的早期替代标志物，预测膀胱尿路上皮癌根治性膀胱切除术患者的5年总体生存率：韩国患者队列的外部评估和验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients [J] . Hyung Suk Kim, Chang Wook Jeong, Cheol Kwak, Frontiers in Oncology . 2015,第6期

机译：2年和3年无病生存是一项重要的早期替代指标，可预测膀胱膀胱癌根治性膀胱切除术治疗患者的5年总体生存：一组韩国患者的外部评估和验证
2. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder [J] . NuhnP., MayM., FritscheH.-M., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2012,第7期

机译：外部验证2或3年无病生存率是膀胱尿路上皮癌根治性膀胱切除术患者的替代和新的主要终点
3. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients [J] . Kim Hyung Suk, Kwak Cheol, Kim Hyeon Hoe, Urologic oncology . 2019,第7期

机译：膀胱风险评估（COBRA）评分用于预测膀胱内切除术后癌症膀胱切除术后的癌症特异性生存率的癌症：韩国患者队列的外部验证
4. Predicting Disease-Free Lung Cancer Survival Using Patient Reported Outcome (PRO) Measurements with Comparisons of Five Machine Learning Techniques (MLT) [C] . Jin-ah Sim, Young Ho Yun MEDINFO . 2019

机译：使用患者报告的结果（PRO）测量来预测无病的肺癌存活，并使用五种机器学习技术（MLT）进行比较
5. Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score [D] . Maawadh, Rawan Mohammed. 2020

机译：预测结肠直肠癌患者的生存：多基因生存率的发展和验证
6. Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients [O] . Hyung Suk Kim, Chang Wook Jeong, Cheol Kwak, 2015

机译：2年和3年无病生存率是一项重要的早期替代指标可以预测膀胱膀胱癌根治性膀胱切除术治疗患者的5年总体生存期：一组韩国患者的外部评估和验证
7. Disease-free survival at 2 and 3 years is a significant early surrogate marker predicting the 5-year overall survival in patients treated with radical cystectomy for urothelial carcinoma of the bladder: external evaluation and validation in a cohort of Korean patients [O] . Hyung Suk eKim, Chang Wook eJeong, Cheol eKwak, 2015

机译：2年和3年的无病生存率是一个重要的早期替代指标，用于预测膀胱尿路上皮癌根治性膀胱切除术患者的5年总生存率：一组韩国患者的外部评估和验证

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients

著录项

引文网络

相似文献

相关主题

期刊订阅